Bruce Booth's Net Worth
$211 Million
Who is Bruce Booth?
Bruce Booth has an estimated net worth of $211 Million. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., MIRAGEN THERAPEUTICS, INC., Unum Therapeutics Inc., Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., ZAFGEN, INC., and AVROBIO, Inc..
SEC CIK
Bruce Booth's CIK is 0001451612
Past Insider Trading and Trends
2018 was Bruce Booth's most active year for acquiring shares with 13 total transactions. Bruce Booth's most active month to acquire stocks was the month of May. 2022 was Bruce Booth's most active year for disposing of shares, totalling 26 transactions. Bruce Booth's most active month to dispose stocks was the month of November. 2019 saw Bruce Booth paying a total of $15,072,875.45 for 911,617 shares, this is the most they've acquired in one year. In 2021 Bruce Booth cashed out on 471,483 shares for a total of $27,728,388.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $2.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +304.67% | 4.39M |
$14.00 |
—
| 5.84M |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MIRAGEN THERAPEUTICS, INC. (VRDN) Snapshot price: $18.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
| +67.70% | 545.45K |
$5.50 | $2,999,997.00 | 1.35M |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Unum Therapeutics Inc. (COGT) Snapshot price: $5.865
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
∞
| 3.36M |
$12.00 |
—
| 3.36M |
Apr 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $34.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.48% | -453.96K |
$38.21 | -$17,346,918.82 | 4.9M |
Scheduled
|
Jul 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| -0.25% | -26.94K |
$35.21 | -$950,174.39 | 10.71M |
Scheduled
|
Jun 12 - Jun 13
| ||
Form 4
| -1.16% | -127.54K |
$40.22 | -$5,133,263.14 | 10.83M |
Scheduled
|
Mar 14 - Mar 15
| ||
Form 4
| -2.04% | -353.36K |
$42.35 | -$14,912,376.40 | 16.96M |
Scheduled
|
Mar 11 - Mar 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| -1.06% | -126.47K |
$30.13 | -$3,821,738.64 | 11.82M |
Scheduled
|
Jan 11 - Jan 12
| ||
Form 4
| -3.09% | -382.24K |
$30.69 | -$11,985,953.69 | 11.97M |
Scheduled
|
Dec 14 - Dec 15
| ||
Form 4
| -1.69% | -220.02K |
$30.01 | -$6,602,952.38 | 12.83M |
Scheduled
|
Nov 2 - Nov 3
| ||
Form 4
| -1.07% | -288.70K |
$30.47 | -$8,735,143.37 | 26.63M |
Scheduled
|
Oct 28 - Nov 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| -100.00% | -242.13K |
$61.00 | -$14,770,113.00 |
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -100.00% | -229.35K |
$56.50 | -$12,958,275.00 |
0
|
Mar 12
| |||
Form 4
| +1,104.37% | 8.31M |
—
|
—
| 9.06M |
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Magenta Therapeutics, Inc. (DNTH) Snapshot price: $22.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 1.25M |
$8.00 | $10,000,000.00 | 1.25M |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| -15.00% | -726.50K |
$17.86 | -$254,415.70 | 4.12M |
Mar 20
| |||
Form 4
| +4,906.38% | 4.75M |
—
|
—
| 4.84M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||